News & Analysis on Clinical Trial Services & Contract Research And Development
Researchers have identified a serine protease inhibitor as a novel candidate susceptibility gene for chronic obstructive pulmonary disease (COPD). The discovery has major implications, especially in smokers, where the role of the cell protease...
Serono and Syntonix Pharmaceuticals announced today that they have entered into an agreement that allows Serono the exclusive rights to use Syntonix' Transceptor and Synfusion technologies for the development and commercialisation of...
Sanofi-Aventis subsidiary Sanofi Pasteur, has been awarded a $97m (€75m) contract to accelerate the production process for new cell culture influenza vaccines in the US and the design of a US-based cell-culture vaccine manufacturing facility.
Researchers have identified several proteins on the surface of cancer cells that contribute to the cells' ability to metastasise. The finding provides unique drug targets to prevent the cancer spread and a basis for which new drug treatments can be...
Researchers have developed miniature sensors that reduce time taken for DNA analysis. The sensors have the same size and thickness as a fingernail and will have uses in testing genetic toxicity in new drugs and identifying bacterial strains in...
Applied Biosystems has launched two new mass spectrometers, which extend the firm's existing product line providing improved performance for proteomics and small molecule applications.
UK firm Denny Bros has introduced a new booklet-style label to the pharma sector that incorporates a secondary, 'pealable' label that can be used for administration or other functions.
The Food and Drug Administration (FDA) has set the end of 2008 as its deadline for the complete phase-out of albuterol inhalers using ozone-depleting chlorofluorocarbons (CFCs) as propellants, reports Phil Taylor.
Shares in German group Altana advanced at the end of last week on the re-emergence of rumours that it is planning to separate its pharmaceuticals and chemicals businesses via a spin-out.